cd19 car‑t safety
CD19 CAR‑T Safety vs Chronic Disease Management?
Surprisingly, 92% of CASTLE participants exhibited no grade 3 or higher cytokine-release syndrome, indicating CD19 CAR-T therapy can be as safe as, or safer than, many chronic disease treatments. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional